Puma Biotechnology
PBYI
PBYI
87 hedge funds and large institutions have $75.2M invested in Puma Biotechnology in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 31 closing their positions.
Holders
87
Holders Change
-17
Holders Change %
-16.35%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
20
Reduced
34
Closed
31
Calls
$231K
Puts
$161K
Net Calls
+$70K
Net Calls Change
+$432K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$6.32M |
| 2 |
CCM
2
Camber Capital Management
Boston,
Massachusetts
|
$12.1M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$853K |
| 4 |
4
Morgan Stanley
New York
|
$1.19M |
| 5 |
5
Renaissance Technologies
New York
|
$5.63M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$5.43M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$518K |
| 3 |
SO
3
STRS Ohio
Columbus,
Ohio
|
$0 |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$1.05M |
| 5 |
5
Goldman Sachs
New York
|
$629K |
